HRT Financial’s Nuvalent NUVL Stock Holding History

HRT Financial’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21,244	Closed	-$288K	–	3283
2022 Q2	$288K	Buy	+21,244	New	+$225K	﹤0.01%	2049

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

HRT Financial's NUVL Position: Q3 2022 in Review

HRT Financial sold out of Nuvalent (NUVL) in Q3 2022, closing a stake of 21,244 shares — an estimated $288K sold.

HRT Financial first reported a position in NUVL in Q2 2022 and held it in 1 quarter. The position peaked at $288K in Q2 2022. 60 funds tracked by Wall St. Rank hold NUVL as of Q3 2022.

HRT Financial reported no remaining Nuvalent position as of Q3 2022 after selling out during the quarter.
HRT Financial sold 21,244 Nuvalent shares in Q3 2022, an estimated $288K.
HRT Financial first reported a position in Nuvalent in Q2 2022 and held it in 1 quarter.
HRT Financial's Nuvalent position peaked at $288K in Q2 2022.
60 funds tracked by Wall St. Rank held Nuvalent as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.